Sunali Wadehra, MD

Changes in N-terminal B-type natriuretic peptide levels from baseline and 6 months were associated with adverse outcomes.

Investigators demonstrated that angina severity at baseline should be a less important aspect of the diagnostic and therapeutic algorithm.

Patients with type 2 diabetes who were initially treated with multiple daily injections were assessed before and after switching to continuous subcutaneous insulin infusion.

HbA1c variability is a strong, independent predictor of all-cause mortality in patients with type 2 diabetes and appears to be more powerful than average HbA1c in predicting all-cause death.

Awareness of ASD and its manifestations and comorbidities remain imperative in the treatment of T1D, as both conditions require long-term medical follow-up to continue improving diabetes care and metabolic control outcomes.